Cargando…
N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice
Sigma receptor antagonists diminish the effects of cocaine in behavioral assays, including conditioned place preference. Previous locomotor activity experiments in mice determined that the sigma receptor ligand YZ-185 (N-phenylpropyl-N′-(3-methoxyphenethyl)piperazine) enhanced cocaine-induced hypera...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780704/ https://www.ncbi.nlm.nih.gov/pubmed/24089641 http://dx.doi.org/10.1155/2013/546314 |
_version_ | 1782285330499502080 |
---|---|
author | Sage, Andrew S. Vannest, Scott C. Fan, Kuo-Hsien Will, Matthew J. Lever, Susan Z. Lever, John R. Miller, Dennis K. |
author_facet | Sage, Andrew S. Vannest, Scott C. Fan, Kuo-Hsien Will, Matthew J. Lever, Susan Z. Lever, John R. Miller, Dennis K. |
author_sort | Sage, Andrew S. |
collection | PubMed |
description | Sigma receptor antagonists diminish the effects of cocaine in behavioral assays, including conditioned place preference. Previous locomotor activity experiments in mice determined that the sigma receptor ligand YZ-185 (N-phenylpropyl-N′-(3-methoxyphenethyl)piperazine) enhanced cocaine-induced hyperactivity at a lower (0.1 μmol/kg) dose and dose-dependently attenuated cocaine-induced hyperactivity at higher (3.16–31.6 μmol/kg) doses. The present study investigated the effect of YZ-185 on cocaine's conditioned-rewarding properties in mice. YZ-185 (0.1, 0.316, 3.16, and 31.6 μmol/kg) did not have intrinsic activity to produce conditioned place preference or aversion. A higher (31.6 μmol/kg) YZ-185 dose, but not lower (0.1–3.16 μmol/kg) YZ-185 doses, prevented the development of place preference to cocaine (66 μmol/kg). YZ-185 did not alter the expression of cocaine place preference. To further characterize YZ-185's behavioral profile, its effects in the elevated zero maze and rotarod procedures were also determined; YZ-185 produced no significant change from baseline in either assay, indicating that the sigma receptors probed by YZ-185 do not regulate anxiety-like or coordinated motor skill behaviors. Overall, these results suggest that YZ-185 is a sigma receptor antagonist at the 31.6 μmol/kg dose and demonstrate that sigma receptors can mediate the development of the conditioned-rewarding properties of cocaine. |
format | Online Article Text |
id | pubmed-3780704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37807042013-10-02 N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice Sage, Andrew S. Vannest, Scott C. Fan, Kuo-Hsien Will, Matthew J. Lever, Susan Z. Lever, John R. Miller, Dennis K. ISRN Pharmacol Research Article Sigma receptor antagonists diminish the effects of cocaine in behavioral assays, including conditioned place preference. Previous locomotor activity experiments in mice determined that the sigma receptor ligand YZ-185 (N-phenylpropyl-N′-(3-methoxyphenethyl)piperazine) enhanced cocaine-induced hyperactivity at a lower (0.1 μmol/kg) dose and dose-dependently attenuated cocaine-induced hyperactivity at higher (3.16–31.6 μmol/kg) doses. The present study investigated the effect of YZ-185 on cocaine's conditioned-rewarding properties in mice. YZ-185 (0.1, 0.316, 3.16, and 31.6 μmol/kg) did not have intrinsic activity to produce conditioned place preference or aversion. A higher (31.6 μmol/kg) YZ-185 dose, but not lower (0.1–3.16 μmol/kg) YZ-185 doses, prevented the development of place preference to cocaine (66 μmol/kg). YZ-185 did not alter the expression of cocaine place preference. To further characterize YZ-185's behavioral profile, its effects in the elevated zero maze and rotarod procedures were also determined; YZ-185 produced no significant change from baseline in either assay, indicating that the sigma receptors probed by YZ-185 do not regulate anxiety-like or coordinated motor skill behaviors. Overall, these results suggest that YZ-185 is a sigma receptor antagonist at the 31.6 μmol/kg dose and demonstrate that sigma receptors can mediate the development of the conditioned-rewarding properties of cocaine. Hindawi Publishing Corporation 2013-09-05 /pmc/articles/PMC3780704/ /pubmed/24089641 http://dx.doi.org/10.1155/2013/546314 Text en Copyright © 2013 Andrew S. Sage et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sage, Andrew S. Vannest, Scott C. Fan, Kuo-Hsien Will, Matthew J. Lever, Susan Z. Lever, John R. Miller, Dennis K. N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice |
title |
N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice |
title_full |
N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice |
title_fullStr |
N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice |
title_full_unstemmed |
N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice |
title_short |
N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice |
title_sort | n-phenylpropyl-n′-(3-methoxyphenethyl)piperazine (yz-185) attenuates the conditioned-rewarding properties of cocaine in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780704/ https://www.ncbi.nlm.nih.gov/pubmed/24089641 http://dx.doi.org/10.1155/2013/546314 |
work_keys_str_mv | AT sageandrews nphenylpropyln3methoxyphenethylpiperazineyz185attenuatestheconditionedrewardingpropertiesofcocaineinmice AT vannestscottc nphenylpropyln3methoxyphenethylpiperazineyz185attenuatestheconditionedrewardingpropertiesofcocaineinmice AT fankuohsien nphenylpropyln3methoxyphenethylpiperazineyz185attenuatestheconditionedrewardingpropertiesofcocaineinmice AT willmatthewj nphenylpropyln3methoxyphenethylpiperazineyz185attenuatestheconditionedrewardingpropertiesofcocaineinmice AT leversusanz nphenylpropyln3methoxyphenethylpiperazineyz185attenuatestheconditionedrewardingpropertiesofcocaineinmice AT leverjohnr nphenylpropyln3methoxyphenethylpiperazineyz185attenuatestheconditionedrewardingpropertiesofcocaineinmice AT millerdennisk nphenylpropyln3methoxyphenethylpiperazineyz185attenuatestheconditionedrewardingpropertiesofcocaineinmice |